NCT06548256View on ClinicalTrials.gov

The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Clostridium Butyricum MiyairiParkinson Disease
Interventions
DRUG

Miyarisan-BM (Clostridium Butyricum Miyairi)

probiotics

Trial Locations (1)

Unknown

RECRUITING

Kaohsiung Medical Univeristy Hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER